Skip to main content

Author: Bill Snyder

REDCap data management tool reaches million user mark

Aug. 15, 2019—Fifteen years after it was launched, REDCap, Vanderbilt University’s research data management tool, has reached 1 million users throughout the world.

Read more


All of Us Research Program Takes Aim at Precision Population Health

Aug. 14, 2019—Scarcely a year after its national launch, the “All of Us” research program, which aims to accelerate the prevention and treatment of disease, has enrolled more than 230,000 research participants — more than a fifth of its recruitment goal of 1 million people. All

Read more


New window on fibrosis

Aug. 8, 2019—A previously unrecognized role for a cell surface receptor may open new therapeutic options for the treatment of fibrotic diseases.

Read more


New role for microtubules in diabetes

Jul. 29, 2019—Microtubules, part of the cell's cytoskeleton, regulate the secretion of insulin, suggesting that they may be a new target for treating diabetes.

Read more


Study ‘ignites’ link between genes and drug response

Jul. 25, 2019—A national study is seeking to determine whether genetic testing can help physicians choose the best drugs for their patients to relieve pain and depression.

Read more


Defective transporter linked to autism

Jul. 24, 2019—A first-of-its-kind mouse model may help reveal mechanistic underpinnings for the altered behaviors of autism spectrum disorder.

Read more


Rasmussen named Vanderbilt Prize Student Scholar

Jul. 18, 2019—Megan Rasmussen, a Ph.D. student in Cell and Developmental Biology, has been selected as the 2019 Vanderbilt Prize Student Scholar.

Read more


Effort seeks to improve safety of drugs given during pregnancy

Jul. 18, 2019—A 19-year-old student is leading a multi-institutional collaboration to identify drugs that can be prescribed safely to pregnant women without harming the fetus.

Read more


More recovery, less disability focus of new research center

Jul. 18, 2019—A new research center is aimed at improving patient outcomes and preventing disability after muscle and skeletal injuries and surgery.

Read more


Vanderbilt team shows how stomach bug can trigger cancer

Jul. 11, 2019—Researchers at Vanderbilt University and the University of Michigan in Ann Arbor have obtained the first high-resolution image of a molecular “machine” used by the insidious stomach bug Helicobacter pylori (H. pylori) to inject a cancer-causing protein into the stomach lining.

Read more


Vanderbilt vaccine pioneer James Crowe honored with major science prize

Jul. 9, 2019—James Crowe Jr., MD, director of the Vanderbilt Vaccine Center, will be honored today by the science and technology company Merck KGaA, Darmstadt, Germany for his contributions to developing new therapeutics and vaccines against some of the world’s deadliest viruses.

Read more


Study explores treatment options for babies with cataracts

Jun. 26, 2019—Cataracts are uncommon in babies but when they occur the cloudy lenses must be removed without delay or blindness may result.

Read more


VIEW MORE EVENTS >